|
US 12,091,413 B2 |
|
| Inhibitors of NEK7 kinase |
| David James Bearss, Salt Lake City, UT (US); John Sai Keong Kauwe, III, Salt Lake City, UT (US); and Alexis Henri Abel Mollard, Lehi, UT (US) |
| Assigned to Halia Therapeutics, Inc., Lehi, UT (US) |
| Filed by Halia Therapeutics, Inc., Salt Lake City, UT (US) |
| Filed on May 23, 2023, as Appl. No. 18/322,380. |
| Application 18/322,380 is a continuation of application No. 17/475,220, filed on Sep. 14, 2021, granted, now 11,713,321. |
| Application 17/475,220 is a continuation of application No. 17/315,209, filed on May 7, 2021, granted, now 11,161,852. |
| Claims priority of provisional application 63/170,761, filed on Apr. 5, 2021. |
| Claims priority of provisional application 63/022,159, filed on May 8, 2020. |
| Prior Publication US 2023/0416259 A1, Dec. 28, 2023 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07D 471/04 (2006.01); A61P 35/02 (2006.01); C07D 487/04 (2006.01) |
